IOVA DRAFT 3

Длинная

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Обновлено

NASDAQ:IOVA Iovance Biotherapeutics, Inc.

trendanalysis waveanalysis beyondta iova iovance pharma pharmaceuticals pharmastocks biotech biotechnology mqp prs

COMPLETE UPDATE FOR IOVA.

Notes: The difference between complete draft and incomplete draft is basically blind spots that show up on different looks. Anyway, under 35 is moderately strong buy for 43-44 late January or early February.

Комментарий:

Notes: Why are there two lines now? A truly complete draft has to consider the zones and bounds of each time frame. I think this will work best in the long run because I can just post what it says rather than what the average is into a singular line.

Link: t.me/BinaryForecastingBot?start=subscribe_plan4028417677-1

Отказ от ответственности

Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.